nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0951	0.189	CbGbCtD
Tacrolimus—CYP3A7—Ifosfamide—germ cell cancer	0.0951	0.189	CbGbCtD
Tacrolimus—CYP3A5—Ifosfamide—germ cell cancer	0.0713	0.142	CbGbCtD
Tacrolimus—ABCB1—Dactinomycin—germ cell cancer	0.0393	0.0782	CbGbCtD
Tacrolimus—CYP3A5—Etoposide—germ cell cancer	0.0341	0.0678	CbGbCtD
Tacrolimus—ALB—Methotrexate—germ cell cancer	0.028	0.0557	CbGbCtD
Tacrolimus—CYP3A4—Ifosfamide—germ cell cancer	0.0278	0.0553	CbGbCtD
Tacrolimus—ABCB1—Vinblastine—germ cell cancer	0.0246	0.049	CbGbCtD
Tacrolimus—ABCB1—Cisplatin—germ cell cancer	0.0226	0.0449	CbGbCtD
Tacrolimus—ABCB1—Etoposide—germ cell cancer	0.0222	0.0441	CbGbCtD
Tacrolimus—CYP3A4—Vinblastine—germ cell cancer	0.0148	0.0293	CbGbCtD
Tacrolimus—ABCB1—Methotrexate—germ cell cancer	0.0147	0.0292	CbGbCtD
Tacrolimus—CYP3A4—Etoposide—germ cell cancer	0.0133	0.0264	CbGbCtD
Tacrolimus—PPP3CA—pons—germ cell cancer	0.0085	0.0606	CbGeAlD
Tacrolimus—PPP3CA—telencephalic ventricle—germ cell cancer	0.007	0.0499	CbGeAlD
Tacrolimus—MTOR—appendage—germ cell cancer	0.0046	0.0328	CbGeAlD
Tacrolimus—PPP3CA—ganglion—germ cell cancer	0.00436	0.0311	CbGeAlD
Tacrolimus—ABCA5—trigeminal ganglion—germ cell cancer	0.00317	0.0226	CbGeAlD
Tacrolimus—ABCA5—eye—germ cell cancer	0.00273	0.0195	CbGeAlD
Tacrolimus—ABCA5—retina—germ cell cancer	0.0027	0.0193	CbGeAlD
Tacrolimus—MTOR—blood vessel—germ cell cancer	0.00256	0.0182	CbGeAlD
Tacrolimus—ABCA5—telencephalon—germ cell cancer	0.00249	0.0177	CbGeAlD
Tacrolimus—ABCA5—decidua—germ cell cancer	0.00236	0.0168	CbGeAlD
Tacrolimus—PPP3CA—trigeminal ganglion—germ cell cancer	0.00214	0.0153	CbGeAlD
Tacrolimus—ABCA5—gonad—germ cell cancer	0.00208	0.0148	CbGeAlD
Tacrolimus—ABCA5—pituitary gland—germ cell cancer	0.00203	0.0144	CbGeAlD
Tacrolimus—ABCA5—medulla oblongata—germ cell cancer	0.00195	0.0139	CbGeAlD
Tacrolimus—PPP3CA—brainstem—germ cell cancer	0.00189	0.0135	CbGeAlD
Tacrolimus—MTOR—neck—germ cell cancer	0.00183	0.013	CbGeAlD
Tacrolimus—PPP3CA—retina—germ cell cancer	0.00183	0.013	CbGeAlD
Tacrolimus—ABCA5—adrenal gland—germ cell cancer	0.00181	0.0129	CbGeAlD
Tacrolimus—ABCA5—midbrain—germ cell cancer	0.00179	0.0127	CbGeAlD
Tacrolimus—ABCA5—bone marrow—germ cell cancer	0.00175	0.0125	CbGeAlD
Tacrolimus—ABCA5—spinal cord—germ cell cancer	0.00174	0.0124	CbGeAlD
Tacrolimus—ABCA5—female gonad—germ cell cancer	0.00169	0.012	CbGeAlD
Tacrolimus—PPP3CA—telencephalon—germ cell cancer	0.00168	0.012	CbGeAlD
Tacrolimus—FKBP1A—neck—germ cell cancer	0.00165	0.0117	CbGeAlD
Tacrolimus—PPP3CA—decidua—germ cell cancer	0.00159	0.0114	CbGeAlD
Tacrolimus—ABCA5—endocrine gland—germ cell cancer	0.00157	0.0112	CbGeAlD
Tacrolimus—ABCA5—head—germ cell cancer	0.00155	0.011	CbGeAlD
Tacrolimus—MTOR—embryo—germ cell cancer	0.00153	0.0109	CbGeAlD
Tacrolimus—ABCA5—testis—germ cell cancer	0.0015	0.0107	CbGeAlD
Tacrolimus—FKBP1A—trigeminal ganglion—germ cell cancer	0.00142	0.0101	CbGeAlD
Tacrolimus—MTOR—brainstem—germ cell cancer	0.0014	0.00997	CbGeAlD
Tacrolimus—PPP3CA—uterus—germ cell cancer	0.00139	0.00993	CbGeAlD
Tacrolimus—CYP3A4—urine—germ cell cancer	0.00139	0.00989	CbGeAlD
Tacrolimus—ABCA5—cerebellum—germ cell cancer	0.00138	0.00985	CbGeAlD
Tacrolimus—PPP3CA—pituitary gland—germ cell cancer	0.00137	0.00975	CbGeAlD
Tacrolimus—MTOR—eye—germ cell cancer	0.00136	0.00971	CbGeAlD
Tacrolimus—MTOR—retina—germ cell cancer	0.00135	0.00962	CbGeAlD
Tacrolimus—PPP3CA—medulla oblongata—germ cell cancer	0.00132	0.00941	CbGeAlD
Tacrolimus—MTOR—telencephalon—germ cell cancer	0.00124	0.00885	CbGeAlD
Tacrolimus—FKBP1A—eye—germ cell cancer	0.00122	0.00873	CbGeAlD
Tacrolimus—PPP3CA—adrenal gland—germ cell cancer	0.00122	0.00871	CbGeAlD
Tacrolimus—FKBP1A—retina—germ cell cancer	0.00121	0.00865	CbGeAlD
Tacrolimus—PPP3CA—midbrain—germ cell cancer	0.00121	0.0086	CbGeAlD
Tacrolimus—MTOR—skin of body—germ cell cancer	0.00118	0.00844	CbGeAlD
Tacrolimus—PPP3CA—bone marrow—germ cell cancer	0.00118	0.00843	CbGeAlD
Tacrolimus—PPP3CA—spinal cord—germ cell cancer	0.00118	0.00839	CbGeAlD
Tacrolimus—PPP3CA—female gonad—germ cell cancer	0.00114	0.00812	CbGeAlD
Tacrolimus—ABCA5—brain—germ cell cancer	0.00112	0.008	CbGeAlD
Tacrolimus—FKBP1A—telencephalon—germ cell cancer	0.00112	0.00796	CbGeAlD
Tacrolimus—ABCA5—lymph node—germ cell cancer	0.00108	0.00773	CbGeAlD
Tacrolimus—FKBP1A—skin of body—germ cell cancer	0.00107	0.00759	CbGeAlD
Tacrolimus—PPP3CA—endocrine gland—germ cell cancer	0.00106	0.00756	CbGeAlD
Tacrolimus—FKBP1A—decidua—germ cell cancer	0.00106	0.00754	CbGeAlD
Tacrolimus—PPP3CA—head—germ cell cancer	0.00105	0.00746	CbGeAlD
Tacrolimus—MTOR—gonad—germ cell cancer	0.00104	0.00738	CbGeAlD
Tacrolimus—MTOR—uterus—germ cell cancer	0.00103	0.00734	CbGeAlD
Tacrolimus—PPP3CA—testis—germ cell cancer	0.00101	0.00721	CbGeAlD
Tacrolimus—MTOR—pituitary gland—germ cell cancer	0.00101	0.0072	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—germ cell cancer	0.000934	0.00665	CbGeAlD
Tacrolimus—FKBP1A—gonad—germ cell cancer	0.000932	0.00664	CbGeAlD
Tacrolimus—FKBP1A—uterus—germ cell cancer	0.000926	0.0066	CbGeAlD
Tacrolimus—FKBP1A—pituitary gland—germ cell cancer	0.000909	0.00648	CbGeAlD
Tacrolimus—MTOR—adrenal gland—germ cell cancer	0.000903	0.00644	CbGeAlD
Tacrolimus—FKBP1A—medulla oblongata—germ cell cancer	0.000877	0.00625	CbGeAlD
Tacrolimus—MTOR—bone marrow—germ cell cancer	0.000873	0.00623	CbGeAlD
Tacrolimus—CYP3A7—endocrine gland—germ cell cancer	0.000871	0.00621	CbGeAlD
Tacrolimus—MTOR—spinal cord—germ cell cancer	0.00087	0.0062	CbGeAlD
Tacrolimus—MTOR—female gonad—germ cell cancer	0.000842	0.006	CbGeAlD
Tacrolimus—FKBP1A—adrenal gland—germ cell cancer	0.000812	0.00579	CbGeAlD
Tacrolimus—FKBP1A—midbrain—germ cell cancer	0.000802	0.00571	CbGeAlD
Tacrolimus—FKBP1A—bone marrow—germ cell cancer	0.000786	0.0056	CbGeAlD
Tacrolimus—MTOR—endocrine gland—germ cell cancer	0.000783	0.00558	CbGeAlD
Tacrolimus—FKBP1A—spinal cord—germ cell cancer	0.000782	0.00558	CbGeAlD
Tacrolimus—MTOR—head—germ cell cancer	0.000773	0.00551	CbGeAlD
Tacrolimus—PPP3CA—brain—germ cell cancer	0.000758	0.00541	CbGeAlD
Tacrolimus—FKBP1A—female gonad—germ cell cancer	0.000757	0.0054	CbGeAlD
Tacrolimus—MTOR—testis—germ cell cancer	0.000747	0.00532	CbGeAlD
Tacrolimus—PPP3CA—lymph node—germ cell cancer	0.000733	0.00522	CbGeAlD
Tacrolimus—FKBP1A—endocrine gland—germ cell cancer	0.000704	0.00502	CbGeAlD
Tacrolimus—FKBP1A—head—germ cell cancer	0.000695	0.00496	CbGeAlD
Tacrolimus—MTOR—cerebellum—germ cell cancer	0.00069	0.00492	CbGeAlD
Tacrolimus—FKBP1A—testis—germ cell cancer	0.000672	0.00479	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—germ cell cancer	0.00062	0.00442	CbGeAlD
Tacrolimus—ORM1—bone marrow—germ cell cancer	0.000615	0.00438	CbGeAlD
Tacrolimus—ORM1—spinal cord—germ cell cancer	0.000612	0.00437	CbGeAlD
Tacrolimus—MTOR—brain—germ cell cancer	0.00056	0.00399	CbGeAlD
Tacrolimus—ALB—adrenal gland—germ cell cancer	0.000557	0.00397	CbGeAlD
Tacrolimus—ORM1—endocrine gland—germ cell cancer	0.000551	0.00393	CbGeAlD
Tacrolimus—MTOR—lymph node—germ cell cancer	0.000541	0.00386	CbGeAlD
Tacrolimus—ABCB1—blood vessel—germ cell cancer	0.000532	0.00379	CbGeAlD
Tacrolimus—FKBP1A—brain—germ cell cancer	0.000504	0.00359	CbGeAlD
Tacrolimus—FKBP1A—lymph node—germ cell cancer	0.000487	0.00347	CbGeAlD
Tacrolimus—ALB—testis—germ cell cancer	0.000461	0.00329	CbGeAlD
Tacrolimus—ORM1—lymph node—germ cell cancer	0.000381	0.00272	CbGeAlD
Tacrolimus—ALB—brain—germ cell cancer	0.000346	0.00247	CbGeAlD
Tacrolimus—ALB—lymph node—germ cell cancer	0.000334	0.00238	CbGeAlD
Tacrolimus—CYP3A5—female gonad—germ cell cancer	0.00033	0.00235	CbGeAlD
Tacrolimus—ABCB1—trigeminal ganglion—germ cell cancer	0.000329	0.00234	CbGeAlD
Tacrolimus—ABCB1—embryo—germ cell cancer	0.000318	0.00226	CbGeAlD
Tacrolimus—CYP3A5—endocrine gland—germ cell cancer	0.000307	0.00219	CbGeAlD
Tacrolimus—ABCB1—retina—germ cell cancer	0.000281	0.002	CbGeAlD
Tacrolimus—ABCB1—telencephalon—germ cell cancer	0.000258	0.00184	CbGeAlD
Tacrolimus—ABCB1—decidua—germ cell cancer	0.000245	0.00174	CbGeAlD
Tacrolimus—CYP3A4—endocrine gland—germ cell cancer	0.00023	0.00164	CbGeAlD
Tacrolimus—ABCB1—gonad—germ cell cancer	0.000216	0.00154	CbGeAlD
Tacrolimus—ABCB1—uterus—germ cell cancer	0.000214	0.00153	CbGeAlD
Tacrolimus—ABCB1—pituitary gland—germ cell cancer	0.00021	0.0015	CbGeAlD
Tacrolimus—ABCB1—medulla oblongata—germ cell cancer	0.000203	0.00145	CbGeAlD
Tacrolimus—MTOR—Signaling by PDGF—FGF4—germ cell cancer	0.0002	0.00408	CbGpPWpGaD
Tacrolimus—MTOR—LKB1 signaling events—MYC—germ cell cancer	0.000196	0.00399	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—FGFR3—germ cell cancer	0.000195	0.00399	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—FGFR3—germ cell cancer	0.000194	0.00396	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—KITLG—germ cell cancer	0.000193	0.00394	CbGpPWpGaD
Tacrolimus—PPP3CA—G Protein Signaling Pathways—HRAS—germ cell cancer	0.00019	0.00388	CbGpPWpGaD
Tacrolimus—MTOR—Alpha 6 Beta 4 signaling pathway—HRAS—germ cell cancer	0.00019	0.00388	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—KITLG—germ cell cancer	0.00019	0.00387	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—germ cell cancer	0.000189	0.00387	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—FGF4—germ cell cancer	0.000189	0.00386	CbGpPWpGaD
Tacrolimus—ABCB1—adrenal gland—germ cell cancer	0.000188	0.00134	CbGeAlD
Tacrolimus—ABCB1—midbrain—germ cell cancer	0.000185	0.00132	CbGeAlD
Tacrolimus—MTOR—PI-3K cascade—KIT—germ cell cancer	0.000184	0.00376	CbGpPWpGaD
Tacrolimus—MTOR—TSLP Signaling Pathway—MYC—germ cell cancer	0.000182	0.00372	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—FGF4—germ cell cancer	0.000182	0.00372	CbGpPWpGaD
Tacrolimus—ABCB1—bone marrow—germ cell cancer	0.000182	0.0013	CbGeAlD
Tacrolimus—Discomfort—Ifosfamide—germ cell cancer	0.000181	0.000588	CcSEcCtD
Tacrolimus—MTOR—Downstream signal transduction—KITLG—germ cell cancer	0.000181	0.0037	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.000181	0.0037	CbGpPWpGaD
Tacrolimus—ABCB1—spinal cord—germ cell cancer	0.000181	0.00129	CbGeAlD
Tacrolimus—MTOR—Signaling by FGFR—KITLG—germ cell cancer	0.00018	0.00368	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Vinblastine—germ cell cancer	0.000179	0.000583	CcSEcCtD
Tacrolimus—MTOR—PI3K/AKT activation—KIT—germ cell cancer	0.000179	0.00367	CbGpPWpGaD
Tacrolimus—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000179	0.000582	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB2—KITLG—germ cell cancer	0.000179	0.00366	CbGpPWpGaD
Tacrolimus—Decreased appetite—Bleomycin—germ cell cancer	0.000179	0.000581	CcSEcCtD
Tacrolimus—Muscle spasms—Cisplatin—germ cell cancer	0.000179	0.00058	CcSEcCtD
Tacrolimus—MTOR—DAP12 signaling—KITLG—germ cell cancer	0.000178	0.00365	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—KIT—germ cell cancer	0.000178	0.00364	CbGpPWpGaD
Tacrolimus—Angiopathy—Etoposide—germ cell cancer	0.000177	0.000576	CcSEcCtD
Tacrolimus—Confusional state—Ifosfamide—germ cell cancer	0.000177	0.000576	CcSEcCtD
Tacrolimus—Immune system disorder—Etoposide—germ cell cancer	0.000177	0.000573	CcSEcCtD
Tacrolimus—Mediastinal disorder—Etoposide—germ cell cancer	0.000176	0.000572	CcSEcCtD
Tacrolimus—Pain—Bleomycin—germ cell cancer	0.000176	0.000571	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KITLG—germ cell cancer	0.000176	0.00359	CbGpPWpGaD
Tacrolimus—Oedema—Ifosfamide—germ cell cancer	0.000176	0.000571	CcSEcCtD
Tacrolimus—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000176	0.000571	CcSEcCtD
Tacrolimus—Chills—Etoposide—germ cell cancer	0.000175	0.000569	CcSEcCtD
Tacrolimus—ABCB1—female gonad—germ cell cancer	0.000175	0.00125	CbGeAlD
Tacrolimus—Vision blurred—Cisplatin—germ cell cancer	0.000175	0.000568	CcSEcCtD
Tacrolimus—MTOR—Signaling by Insulin receptor—FGFR3—germ cell cancer	0.000175	0.00357	CbGpPWpGaD
Tacrolimus—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000175	0.000568	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000175	0.000568	CcSEcCtD
Tacrolimus—Asthenia—Vinblastine—germ cell cancer	0.000175	0.000567	CcSEcCtD
Tacrolimus—Infection—Ifosfamide—germ cell cancer	0.000175	0.000567	CcSEcCtD
Tacrolimus—Tremor—Cisplatin—germ cell cancer	0.000174	0.000565	CcSEcCtD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—germ cell cancer	0.000174	0.00355	CbGpPWpGaD
Tacrolimus—Alopecia—Etoposide—germ cell cancer	0.000173	0.000561	CcSEcCtD
Tacrolimus—Nervous system disorder—Ifosfamide—germ cell cancer	0.000172	0.00056	CcSEcCtD
Tacrolimus—Ill-defined disorder—Cisplatin—germ cell cancer	0.000172	0.00056	CcSEcCtD
Tacrolimus—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000172	0.000559	CcSEcCtD
Tacrolimus—Anaemia—Cisplatin—germ cell cancer	0.000172	0.000557	CcSEcCtD
Tacrolimus—Skin disorder—Ifosfamide—germ cell cancer	0.000171	0.000555	CcSEcCtD
Tacrolimus—PPP3CA—Disease—SLC2A3—germ cell cancer	0.00017	0.00348	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00017	0.000552	CcSEcCtD
Tacrolimus—Feeling abnormal—Bleomycin—germ cell cancer	0.00017	0.00055	CcSEcCtD
Tacrolimus—MTOR—CXCR3-mediated signaling events—HRAS—germ cell cancer	0.00017	0.00346	CbGpPWpGaD
Tacrolimus—Osteoarthritis—Methotrexate—germ cell cancer	0.000169	0.000549	CcSEcCtD
Tacrolimus—MTOR—Wnt Signaling Pathway Netpath—MYC—germ cell cancer	0.000168	0.00343	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—KITLG—germ cell cancer	0.000168	0.00343	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.000168	0.00343	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—KITLG—germ cell cancer	0.000168	0.00343	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PVRL2—germ cell cancer	0.000168	0.00343	CbGpPWpGaD
Tacrolimus—Anorexia—Ifosfamide—germ cell cancer	0.000168	0.000544	CcSEcCtD
Tacrolimus—Malaise—Cisplatin—germ cell cancer	0.000167	0.000544	CcSEcCtD
Tacrolimus—Decreased appetite—Dactinomycin—germ cell cancer	0.000167	0.000542	CcSEcCtD
Tacrolimus—Diarrhoea—Vinblastine—germ cell cancer	0.000167	0.000541	CcSEcCtD
Tacrolimus—Dysgeusia—Etoposide—germ cell cancer	0.000167	0.000541	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR—KITLG—germ cell cancer	0.000166	0.0034	CbGpPWpGaD
Tacrolimus—Leukopenia—Cisplatin—germ cell cancer	0.000166	0.00054	CcSEcCtD
Tacrolimus—Fatigue—Dactinomycin—germ cell cancer	0.000165	0.000537	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.000165	0.00337	CbGpPWpGaD
Tacrolimus—Back pain—Etoposide—germ cell cancer	0.000165	0.000534	CcSEcCtD
Tacrolimus—Hypotension—Ifosfamide—germ cell cancer	0.000164	0.000533	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—TP53—germ cell cancer	0.000164	0.00335	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—KITLG—germ cell cancer	0.000164	0.00335	CbGpPWpGaD
Tacrolimus—Pain—Dactinomycin—germ cell cancer	0.000164	0.000533	CcSEcCtD
Tacrolimus—Muscle spasms—Etoposide—germ cell cancer	0.000164	0.000531	CcSEcCtD
Tacrolimus—Urticaria—Bleomycin—germ cell cancer	0.000163	0.000531	CcSEcCtD
Tacrolimus—MTOR—ErbB Signaling Pathway—MYC—germ cell cancer	0.000163	0.00333	CbGpPWpGaD
Tacrolimus—ABCB1—endocrine gland—germ cell cancer	0.000163	0.00116	CbGeAlD
Tacrolimus—Body temperature increased—Bleomycin—germ cell cancer	0.000163	0.000528	CcSEcCtD
Tacrolimus—Dizziness—Vinblastine—germ cell cancer	0.000161	0.000523	CcSEcCtD
Tacrolimus—Convulsion—Cisplatin—germ cell cancer	0.000161	0.000522	CcSEcCtD
Tacrolimus—ABCB1—head—germ cell cancer	0.000161	0.00115	CbGeAlD
Tacrolimus—MTOR—LKB1 signaling events—TP53—germ cell cancer	0.000161	0.00328	CbGpPWpGaD
Tacrolimus—Mood swings—Methotrexate—germ cell cancer	0.00016	0.000521	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00016	0.00052	CcSEcCtD
Tacrolimus—MTOR—ErbB2/ErbB3 signaling events—HRAS—germ cell cancer	0.00016	0.00326	CbGpPWpGaD
Tacrolimus—Myalgia—Cisplatin—germ cell cancer	0.000158	0.000513	CcSEcCtD
Tacrolimus—Feeling abnormal—Dactinomycin—germ cell cancer	0.000158	0.000513	CcSEcCtD
Tacrolimus—Paraesthesia—Ifosfamide—germ cell cancer	0.000158	0.000513	CcSEcCtD
Tacrolimus—Ill-defined disorder—Etoposide—germ cell cancer	0.000158	0.000513	CcSEcCtD
Tacrolimus—Anxiety—Cisplatin—germ cell cancer	0.000158	0.000512	CcSEcCtD
Tacrolimus—Anaemia—Etoposide—germ cell cancer	0.000157	0.000511	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000157	0.00051	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000157	0.000509	CcSEcCtD
Tacrolimus—Dyspnoea—Ifosfamide—germ cell cancer	0.000157	0.000509	CcSEcCtD
Tacrolimus—Somnolence—Ifosfamide—germ cell cancer	0.000156	0.000508	CcSEcCtD
Tacrolimus—Liver function test abnormal—Methotrexate—germ cell cancer	0.000156	0.000507	CcSEcCtD
Tacrolimus—Discomfort—Cisplatin—germ cell cancer	0.000156	0.000507	CcSEcCtD
Tacrolimus—MTOR—B Cell Activation—KITLG—germ cell cancer	0.000155	0.00317	CbGpPWpGaD
Tacrolimus—ABCB1—testis—germ cell cancer	0.000155	0.00111	CbGeAlD
Tacrolimus—FKBP1A—Spinal Cord Injury—MYC—germ cell cancer	0.000155	0.00317	CbGpPWpGaD
Tacrolimus—Vomiting—Vinblastine—germ cell cancer	0.000155	0.000503	CcSEcCtD
Tacrolimus—Malaise—Etoposide—germ cell cancer	0.000153	0.000498	CcSEcCtD
Tacrolimus—Breast disorder—Methotrexate—germ cell cancer	0.000153	0.000497	CcSEcCtD
Tacrolimus—Vertigo—Etoposide—germ cell cancer	0.000153	0.000496	CcSEcCtD
Tacrolimus—Decreased appetite—Ifosfamide—germ cell cancer	0.000153	0.000496	CcSEcCtD
Tacrolimus—Headache—Vinblastine—germ cell cancer	0.000153	0.000495	CcSEcCtD
Tacrolimus—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000152	0.000495	CcSEcCtD
Tacrolimus—Leukopenia—Etoposide—germ cell cancer	0.000152	0.000495	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000152	0.000493	CcSEcCtD
Tacrolimus—Body temperature increased—Dactinomycin—germ cell cancer	0.000152	0.000492	CcSEcCtD
Tacrolimus—Abdominal pain—Dactinomycin—germ cell cancer	0.000152	0.000492	CcSEcCtD
Tacrolimus—Fatigue—Ifosfamide—germ cell cancer	0.000152	0.000492	CcSEcCtD
Tacrolimus—Anaphylactic shock—Cisplatin—germ cell cancer	0.000152	0.000492	CcSEcCtD
Tacrolimus—Oedema—Cisplatin—germ cell cancer	0.000152	0.000492	CcSEcCtD
Tacrolimus—Hypersensitivity—Bleomycin—germ cell cancer	0.000152	0.000492	CcSEcCtD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—MYC—germ cell cancer	0.000151	0.00308	CbGpPWpGaD
Tacrolimus—Infection—Cisplatin—germ cell cancer	0.000151	0.000489	CcSEcCtD
Tacrolimus—Pain—Ifosfamide—germ cell cancer	0.00015	0.000488	CcSEcCtD
Tacrolimus—Constipation—Ifosfamide—germ cell cancer	0.00015	0.000488	CcSEcCtD
Tacrolimus—MTOR—Signaling by SCF-KIT—FGFR3—germ cell cancer	0.00015	0.00306	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—KITLG—germ cell cancer	0.00015	0.00306	CbGpPWpGaD
Tacrolimus—Loss of consciousness—Etoposide—germ cell cancer	0.00015	0.000486	CcSEcCtD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000149	0.00304	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Cisplatin—germ cell cancer	0.000149	0.000483	CcSEcCtD
Tacrolimus—Cough—Etoposide—germ cell cancer	0.000148	0.000482	CcSEcCtD
Tacrolimus—Thrombocytopenia—Cisplatin—germ cell cancer	0.000148	0.000482	CcSEcCtD
Tacrolimus—Tachycardia—Cisplatin—germ cell cancer	0.000148	0.00048	CcSEcCtD
Tacrolimus—Asthenia—Bleomycin—germ cell cancer	0.000148	0.000479	CcSEcCtD
Tacrolimus—Convulsion—Etoposide—germ cell cancer	0.000147	0.000479	CcSEcCtD
Tacrolimus—Skin disorder—Cisplatin—germ cell cancer	0.000147	0.000478	CcSEcCtD
Tacrolimus—Hypertension—Etoposide—germ cell cancer	0.000147	0.000477	CcSEcCtD
Tacrolimus—Hyperhidrosis—Cisplatin—germ cell cancer	0.000147	0.000476	CcSEcCtD
Tacrolimus—Asthma—Methotrexate—germ cell cancer	0.000146	0.000475	CcSEcCtD
Tacrolimus—Pruritus—Bleomycin—germ cell cancer	0.000146	0.000473	CcSEcCtD
Tacrolimus—Feeling abnormal—Ifosfamide—germ cell cancer	0.000145	0.00047	CcSEcCtD
Tacrolimus—Chest pain—Etoposide—germ cell cancer	0.000145	0.00047	CcSEcCtD
Tacrolimus—Nausea—Vinblastine—germ cell cancer	0.000145	0.00047	CcSEcCtD
Tacrolimus—Anorexia—Cisplatin—germ cell cancer	0.000144	0.000469	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000144	0.000467	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000144	0.000467	CcSEcCtD
Tacrolimus—ABCB1—cerebellum—germ cell cancer	0.000143	0.00102	CbGeAlD
Tacrolimus—Pancreatitis—Methotrexate—germ cell cancer	0.000143	0.000466	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	0.000143	0.00293	CbGpPWpGaD
Tacrolimus—Discomfort—Etoposide—germ cell cancer	0.000143	0.000465	CcSEcCtD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000142	0.0029	CbGpPWpGaD
Tacrolimus—Hypotension—Cisplatin—germ cell cancer	0.000142	0.00046	CcSEcCtD
Tacrolimus—Hypersensitivity—Dactinomycin—germ cell cancer	0.000141	0.000459	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—FGFR3—germ cell cancer	0.000141	0.00288	CbGpPWpGaD
Tacrolimus—Confusional state—Etoposide—germ cell cancer	0.00014	0.000455	CcSEcCtD
Tacrolimus—Urticaria—Ifosfamide—germ cell cancer	0.00014	0.000454	CcSEcCtD
Tacrolimus—MTOR—Signaling by NGF—FGF4—germ cell cancer	0.000139	0.00284	CbGpPWpGaD
Tacrolimus—Abdominal pain—Ifosfamide—germ cell cancer	0.000139	0.000451	CcSEcCtD
Tacrolimus—Body temperature increased—Ifosfamide—germ cell cancer	0.000139	0.000451	CcSEcCtD
Tacrolimus—Pancytopenia—Methotrexate—germ cell cancer	0.000139	0.000451	CcSEcCtD
Tacrolimus—Anaphylactic shock—Etoposide—germ cell cancer	0.000139	0.000451	CcSEcCtD
Tacrolimus—MTOR—TSH signaling pathway—MYC—germ cell cancer	0.000139	0.00283	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000138	0.000448	CcSEcCtD
Tacrolimus—Infection—Etoposide—germ cell cancer	0.000138	0.000448	CcSEcCtD
Tacrolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000138	0.00281	CbGpPWpGaD
Tacrolimus—Asthenia—Dactinomycin—germ cell cancer	0.000138	0.000447	CcSEcCtD
Tacrolimus—MTOR—Signaling by SCF-KIT—KIT—germ cell cancer	0.000137	0.00281	CbGpPWpGaD
Tacrolimus—Neutropenia—Methotrexate—germ cell cancer	0.000137	0.000444	CcSEcCtD
Tacrolimus—Dysuria—Methotrexate—germ cell cancer	0.000137	0.000444	CcSEcCtD
Tacrolimus—Paraesthesia—Cisplatin—germ cell cancer	0.000136	0.000442	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—OXT—germ cell cancer	0.000136	0.00278	CbGpPWpGaD
Tacrolimus—Thrombocytopenia—Etoposide—germ cell cancer	0.000136	0.000441	CcSEcCtD
Tacrolimus—Tachycardia—Etoposide—germ cell cancer	0.000136	0.00044	CcSEcCtD
Tacrolimus—MTOR—Regulation of Telomerase—MYC—germ cell cancer	0.000135	0.00277	CbGpPWpGaD
Tacrolimus—Dyspnoea—Cisplatin—germ cell cancer	0.000135	0.000439	CcSEcCtD
Tacrolimus—Skin disorder—Etoposide—germ cell cancer	0.000135	0.000438	CcSEcCtD
Tacrolimus—MTOR—Downstream signal transduction—FGFR3—germ cell cancer	0.000135	0.00275	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Etoposide—germ cell cancer	0.000134	0.000436	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR—FGFR3—germ cell cancer	0.000134	0.00274	CbGpPWpGaD
Tacrolimus—MTOR—ErbB Signaling Pathway—TP53—germ cell cancer	0.000134	0.00273	CbGpPWpGaD
Tacrolimus—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000134	0.000433	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB2—FGFR3—germ cell cancer	0.000133	0.00272	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—FGFR3—germ cell cancer	0.000133	0.00271	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—H2AFZ—germ cell cancer	0.000133	0.00271	CbGpPWpGaD
Tacrolimus—Anorexia—Etoposide—germ cell cancer	0.000132	0.00043	CcSEcCtD
Tacrolimus—FKBP1A—Disease—SLC2A3—germ cell cancer	0.000132	0.0027	CbGpPWpGaD
Tacrolimus—Decreased appetite—Cisplatin—germ cell cancer	0.000132	0.000428	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000131	0.00269	CbGpPWpGaD
Tacrolimus—Diarrhoea—Dactinomycin—germ cell cancer	0.000131	0.000426	CcSEcCtD
Tacrolimus—Pneumonia—Methotrexate—germ cell cancer	0.000131	0.000426	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000131	0.000425	CcSEcCtD
Tacrolimus—Vomiting—Bleomycin—germ cell cancer	0.000131	0.000425	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.000131	0.00267	CbGpPWpGaD
Tacrolimus—Infestation NOS—Methotrexate—germ cell cancer	0.00013	0.000423	CcSEcCtD
Tacrolimus—Infestation—Methotrexate—germ cell cancer	0.00013	0.000423	CcSEcCtD
Tacrolimus—Depression—Methotrexate—germ cell cancer	0.00013	0.000422	CcSEcCtD
Tacrolimus—Hypotension—Etoposide—germ cell cancer	0.00013	0.000421	CcSEcCtD
Tacrolimus—Rash—Bleomycin—germ cell cancer	0.00013	0.000421	CcSEcCtD
Tacrolimus—Pain—Cisplatin—germ cell cancer	0.00013	0.000421	CcSEcCtD
Tacrolimus—Dermatitis—Bleomycin—germ cell cancer	0.00013	0.000421	CcSEcCtD
Tacrolimus—Hypersensitivity—Ifosfamide—germ cell cancer	0.00013	0.000421	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—KIT—germ cell cancer	0.000129	0.00264	CbGpPWpGaD
Tacrolimus—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000129	0.00042	CcSEcCtD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000129	0.00263	CbGpPWpGaD
Tacrolimus—Renal failure—Methotrexate—germ cell cancer	0.000128	0.000416	CcSEcCtD
Tacrolimus—MTOR—ErbB Signaling Pathway—HRAS—germ cell cancer	0.000128	0.00261	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TP53—germ cell cancer	0.000127	0.0026	CbGpPWpGaD
Tacrolimus—Stomatitis—Methotrexate—germ cell cancer	0.000127	0.000413	CcSEcCtD
Tacrolimus—Conjunctivitis—Methotrexate—germ cell cancer	0.000127	0.000412	CcSEcCtD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000127	0.00259	CbGpPWpGaD
Tacrolimus—Asthenia—Ifosfamide—germ cell cancer	0.000126	0.00041	CcSEcCtD
Tacrolimus—Sweating—Methotrexate—germ cell cancer	0.000125	0.000406	CcSEcCtD
Tacrolimus—Feeling abnormal—Cisplatin—germ cell cancer	0.000125	0.000406	CcSEcCtD
Tacrolimus—MTOR—DAP12 interactions—FGFR3—germ cell cancer	0.000125	0.00255	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000125	0.00255	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000125	0.00255	CbGpPWpGaD
Tacrolimus—Paraesthesia—Etoposide—germ cell cancer	0.000125	0.000405	CcSEcCtD
Tacrolimus—Pruritus—Ifosfamide—germ cell cancer	0.000124	0.000404	CcSEcCtD
Tacrolimus—Haematuria—Methotrexate—germ cell cancer	0.000124	0.000404	CcSEcCtD
Tacrolimus—Dyspnoea—Etoposide—germ cell cancer	0.000124	0.000402	CcSEcCtD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TP53—germ cell cancer	0.000124	0.00253	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—FGFR3—germ cell cancer	0.000124	0.00253	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—KIT—germ cell cancer	0.000124	0.00252	CbGpPWpGaD
Tacrolimus—Somnolence—Etoposide—germ cell cancer	0.000123	0.000401	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000123	0.0004	CcSEcCtD
Tacrolimus—Epistaxis—Methotrexate—germ cell cancer	0.000123	0.000399	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR—KIT—germ cell cancer	0.000123	0.00251	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000123	0.0025	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—KIT—germ cell cancer	0.000122	0.0025	CbGpPWpGaD
Tacrolimus—Nausea—Bleomycin—germ cell cancer	0.000122	0.000397	CcSEcCtD
Tacrolimus—MTOR—Signaling by PDGF—FGFR3—germ cell cancer	0.000122	0.00249	CbGpPWpGaD
Tacrolimus—Vomiting—Dactinomycin—germ cell cancer	0.000122	0.000396	CcSEcCtD
Tacrolimus—MTOR—DAP12 signaling—KIT—germ cell cancer	0.000122	0.00249	CbGpPWpGaD
Tacrolimus—Agranulocytosis—Methotrexate—germ cell cancer	0.000122	0.000395	CcSEcCtD
Tacrolimus—Rash—Dactinomycin—germ cell cancer	0.000121	0.000393	CcSEcCtD
Tacrolimus—Decreased appetite—Etoposide—germ cell cancer	0.000121	0.000392	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—PVRL2—germ cell cancer	0.000121	0.00247	CbGpPWpGaD
Tacrolimus—Diarrhoea—Ifosfamide—germ cell cancer	0.00012	0.000391	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.00012	0.00245	CbGpPWpGaD
Tacrolimus—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00012	0.000389	CcSEcCtD
Tacrolimus—Body temperature increased—Cisplatin—germ cell cancer	0.00012	0.000389	CcSEcCtD
Tacrolimus—Fatigue—Etoposide—germ cell cancer	0.00012	0.000389	CcSEcCtD
Tacrolimus—Pain—Etoposide—germ cell cancer	0.000119	0.000386	CcSEcCtD
Tacrolimus—Constipation—Etoposide—germ cell cancer	0.000119	0.000386	CcSEcCtD
Tacrolimus—PPP3CA—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000118	0.00242	CbGpPWpGaD
Tacrolimus—Haemoglobin—Methotrexate—germ cell cancer	0.000118	0.000382	CcSEcCtD
Tacrolimus—Haemorrhage—Methotrexate—germ cell cancer	0.000117	0.00038	CcSEcCtD
Tacrolimus—Hepatitis—Methotrexate—germ cell cancer	0.000117	0.00038	CcSEcCtD
Tacrolimus—ABCB1—brain—germ cell cancer	0.000117	0.000831	CbGeAlD
Tacrolimus—Dizziness—Ifosfamide—germ cell cancer	0.000116	0.000378	CcSEcCtD
Tacrolimus—Pharyngitis—Methotrexate—germ cell cancer	0.000116	0.000377	CcSEcCtD
Tacrolimus—Urinary tract disorder—Methotrexate—germ cell cancer	0.000116	0.000375	CcSEcCtD
Tacrolimus—MTOR—B Cell Activation—FGFR3—germ cell cancer	0.000115	0.00236	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000115	0.00236	CbGpPWpGaD
Tacrolimus—Urethral disorder—Methotrexate—germ cell cancer	0.000115	0.000373	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR in disease—KIT—germ cell cancer	0.000115	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000115	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—KIT—germ cell cancer	0.000115	0.00234	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Etoposide—germ cell cancer	0.000114	0.000372	CcSEcCtD
Tacrolimus—MTOR—Signaling by NGF—KITLG—germ cell cancer	0.000114	0.00234	CbGpPWpGaD
Tacrolimus—Nausea—Dactinomycin—germ cell cancer	0.000114	0.00037	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Etoposide—germ cell cancer	0.000114	0.000369	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR—KIT—germ cell cancer	0.000114	0.00232	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000114	0.00232	CbGpPWpGaD
Tacrolimus—Visual impairment—Methotrexate—germ cell cancer	0.000113	0.000366	CcSEcCtD
Tacrolimus—ABCB1—lymph node—germ cell cancer	0.000113	0.000803	CbGeAlD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000113	0.0023	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—KIT—germ cell cancer	0.000112	0.00229	CbGpPWpGaD
Tacrolimus—Vomiting—Ifosfamide—germ cell cancer	0.000112	0.000363	CcSEcCtD
Tacrolimus—Hypersensitivity—Cisplatin—germ cell cancer	0.000112	0.000363	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—FGFR3—germ cell cancer	0.000111	0.00227	CbGpPWpGaD
Tacrolimus—Rash—Ifosfamide—germ cell cancer	0.000111	0.00036	CcSEcCtD
Tacrolimus—Dermatitis—Ifosfamide—germ cell cancer	0.000111	0.00036	CcSEcCtD
Tacrolimus—Erythema multiforme—Methotrexate—germ cell cancer	0.000111	0.000359	CcSEcCtD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000111	0.00226	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.00011	0.00225	CbGpPWpGaD
Tacrolimus—Urticaria—Etoposide—germ cell cancer	0.00011	0.000358	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by WNT in cancer—MYC—germ cell cancer	0.00011	0.00225	CbGpPWpGaD
Tacrolimus—MTOR—AMPK Signaling—TP53—germ cell cancer	0.00011	0.00225	CbGpPWpGaD
Tacrolimus—Body temperature increased—Etoposide—germ cell cancer	0.00011	0.000356	CcSEcCtD
Tacrolimus—Abdominal pain—Etoposide—germ cell cancer	0.00011	0.000356	CcSEcCtD
Tacrolimus—Eye disorder—Methotrexate—germ cell cancer	0.000109	0.000355	CcSEcCtD
Tacrolimus—Tinnitus—Methotrexate—germ cell cancer	0.000109	0.000354	CcSEcCtD
Tacrolimus—MTOR—TSH signaling pathway—HRAS—germ cell cancer	0.000109	0.00223	CbGpPWpGaD
Tacrolimus—MTOR—mTOR signaling pathway—HRAS—germ cell cancer	0.000109	0.00223	CbGpPWpGaD
Tacrolimus—Asthenia—Cisplatin—germ cell cancer	0.000109	0.000353	CcSEcCtD
Tacrolimus—Cardiac disorder—Methotrexate—germ cell cancer	0.000109	0.000353	CcSEcCtD
Tacrolimus—Angiopathy—Methotrexate—germ cell cancer	0.000106	0.000345	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—FGF4—germ cell cancer	0.000106	0.00217	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—KIT—germ cell cancer	0.000106	0.00217	CbGpPWpGaD
Tacrolimus—Immune system disorder—Methotrexate—germ cell cancer	0.000106	0.000343	CcSEcCtD
Tacrolimus—Mediastinal disorder—Methotrexate—germ cell cancer	0.000106	0.000343	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000105	0.00215	CbGpPWpGaD
Tacrolimus—Chills—Methotrexate—germ cell cancer	0.000105	0.000341	CcSEcCtD
Tacrolimus—Nausea—Ifosfamide—germ cell cancer	0.000104	0.000339	CcSEcCtD
Tacrolimus—MTOR—CDC42 signaling events—HRAS—germ cell cancer	0.000104	0.00212	CbGpPWpGaD
Tacrolimus—Diarrhoea—Cisplatin—germ cell cancer	0.000104	0.000337	CcSEcCtD
Tacrolimus—Alopecia—Methotrexate—germ cell cancer	0.000103	0.000336	CcSEcCtD
Tacrolimus—Mental disorder—Methotrexate—germ cell cancer	0.000103	0.000333	CcSEcCtD
Tacrolimus—Hypersensitivity—Etoposide—germ cell cancer	0.000102	0.000332	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—KIT—germ cell cancer	0.000102	0.00208	CbGpPWpGaD
Tacrolimus—Erythema—Methotrexate—germ cell cancer	0.000102	0.000331	CcSEcCtD
Tacrolimus—Malnutrition—Methotrexate—germ cell cancer	0.000102	0.000331	CcSEcCtD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000101	0.00207	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.98e-05	0.00204	CbGpPWpGaD
Tacrolimus—Dysgeusia—Methotrexate—germ cell cancer	9.98e-05	0.000324	CcSEcCtD
Tacrolimus—Asthenia—Etoposide—germ cell cancer	9.96e-05	0.000323	CcSEcCtD
Tacrolimus—Back pain—Methotrexate—germ cell cancer	9.86e-05	0.00032	CcSEcCtD
Tacrolimus—MTOR—Leptin signaling pathway—HRAS—germ cell cancer	9.84e-05	0.00201	CbGpPWpGaD
Tacrolimus—Pruritus—Etoposide—germ cell cancer	9.82e-05	0.000319	CcSEcCtD
Tacrolimus—PPP3CA—Disease—FGF4—germ cell cancer	9.79e-05	0.002	CbGpPWpGaD
Tacrolimus—Vomiting—Cisplatin—germ cell cancer	9.64e-05	0.000313	CcSEcCtD
Tacrolimus—Vision blurred—Methotrexate—germ cell cancer	9.6e-05	0.000312	CcSEcCtD
Tacrolimus—Rash—Cisplatin—germ cell cancer	9.56e-05	0.00031	CcSEcCtD
Tacrolimus—Dermatitis—Cisplatin—germ cell cancer	9.55e-05	0.00031	CcSEcCtD
Tacrolimus—Diarrhoea—Etoposide—germ cell cancer	9.5e-05	0.000308	CcSEcCtD
Tacrolimus—Ill-defined disorder—Methotrexate—germ cell cancer	9.46e-05	0.000307	CcSEcCtD
Tacrolimus—Anaemia—Methotrexate—germ cell cancer	9.42e-05	0.000306	CcSEcCtD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	9.34e-05	0.00191	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AVP—germ cell cancer	9.32e-05	0.0019	CbGpPWpGaD
Tacrolimus—Malaise—Methotrexate—germ cell cancer	9.19e-05	0.000298	CcSEcCtD
Tacrolimus—Dizziness—Etoposide—germ cell cancer	9.18e-05	0.000298	CcSEcCtD
Tacrolimus—Vertigo—Methotrexate—germ cell cancer	9.16e-05	0.000297	CcSEcCtD
Tacrolimus—Leukopenia—Methotrexate—germ cell cancer	9.12e-05	0.000296	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by Wnt—MYC—germ cell cancer	9.07e-05	0.00185	CbGpPWpGaD
Tacrolimus—Nausea—Cisplatin—germ cell cancer	9e-05	0.000292	CcSEcCtD
Tacrolimus—MTOR—IRS-mediated signalling—HRAS—germ cell cancer	8.9e-05	0.00182	CbGpPWpGaD
Tacrolimus—Cough—Methotrexate—germ cell cancer	8.89e-05	0.000289	CcSEcCtD
Tacrolimus—Convulsion—Methotrexate—germ cell cancer	8.83e-05	0.000287	CcSEcCtD
Tacrolimus—Vomiting—Etoposide—germ cell cancer	8.83e-05	0.000287	CcSEcCtD
Tacrolimus—Rash—Etoposide—germ cell cancer	8.76e-05	0.000284	CcSEcCtD
Tacrolimus—Dermatitis—Etoposide—germ cell cancer	8.75e-05	0.000284	CcSEcCtD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.75e-05	0.00179	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—H2AFZ—germ cell cancer	8.74e-05	0.00179	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—KITLG—germ cell cancer	8.71e-05	0.00178	CbGpPWpGaD
Tacrolimus—Headache—Etoposide—germ cell cancer	8.7e-05	0.000282	CcSEcCtD
Tacrolimus—Myalgia—Methotrexate—germ cell cancer	8.68e-05	0.000282	CcSEcCtD
Tacrolimus—Arthralgia—Methotrexate—germ cell cancer	8.68e-05	0.000282	CcSEcCtD
Tacrolimus—Chest pain—Methotrexate—germ cell cancer	8.68e-05	0.000282	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.66e-05	0.00177	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—HRAS—germ cell cancer	8.66e-05	0.00177	CbGpPWpGaD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	8.62e-05	0.00028	CcSEcCtD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—germ cell cancer	8.58e-05	0.00175	CbGpPWpGaD
Tacrolimus—Discomfort—Methotrexate—germ cell cancer	8.57e-05	0.000278	CcSEcCtD
Tacrolimus—MTOR—Signaling by NGF—FGFR3—germ cell cancer	8.5e-05	0.00174	CbGpPWpGaD
Tacrolimus—Confusional state—Methotrexate—germ cell cancer	8.39e-05	0.000272	CcSEcCtD
Tacrolimus—MTOR—Insulin receptor signalling cascade—HRAS—germ cell cancer	8.36e-05	0.00171	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—HRAS—germ cell cancer	8.36e-05	0.00171	CbGpPWpGaD
Tacrolimus—Anaphylactic shock—Methotrexate—germ cell cancer	8.32e-05	0.00027	CcSEcCtD
Tacrolimus—Infection—Methotrexate—germ cell cancer	8.26e-05	0.000268	CcSEcCtD
Tacrolimus—Nausea—Etoposide—germ cell cancer	8.25e-05	0.000268	CcSEcCtD
Tacrolimus—Nervous system disorder—Methotrexate—germ cell cancer	8.16e-05	0.000265	CcSEcCtD
Tacrolimus—Thrombocytopenia—Methotrexate—germ cell cancer	8.14e-05	0.000264	CcSEcCtD
Tacrolimus—Skin disorder—Methotrexate—germ cell cancer	8.08e-05	0.000262	CcSEcCtD
Tacrolimus—PPP3CA—Disease—KITLG—germ cell cancer	8.04e-05	0.00164	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Methotrexate—germ cell cancer	8.04e-05	0.000261	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—OXT—germ cell cancer	8.03e-05	0.00164	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—FGF4—germ cell cancer	7.94e-05	0.00162	CbGpPWpGaD
Tacrolimus—Anorexia—Methotrexate—germ cell cancer	7.93e-05	0.000257	CcSEcCtD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—germ cell cancer	7.86e-05	0.00161	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—KIT—germ cell cancer	7.8e-05	0.00159	CbGpPWpGaD
Tacrolimus—Hypotension—Methotrexate—germ cell cancer	7.77e-05	0.000252	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—FGF4—germ cell cancer	7.62e-05	0.00156	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—FGF4—germ cell cancer	7.59e-05	0.00155	CbGpPWpGaD
Tacrolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	7.58e-05	0.00155	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Methotrexate—germ cell cancer	7.58e-05	0.000246	CcSEcCtD
Tacrolimus—Insomnia—Methotrexate—germ cell cancer	7.52e-05	0.000244	CcSEcCtD
Tacrolimus—MTOR—ErbB1 downstream signaling—HRAS—germ cell cancer	7.52e-05	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	7.52e-05	0.00154	CbGpPWpGaD
Tacrolimus—Paraesthesia—Methotrexate—germ cell cancer	7.47e-05	0.000243	CcSEcCtD
Tacrolimus—MTOR—Disease—SLC2A3—germ cell cancer	7.43e-05	0.00152	CbGpPWpGaD
Tacrolimus—Dyspnoea—Methotrexate—germ cell cancer	7.42e-05	0.000241	CcSEcCtD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	7.4e-05	0.00151	CbGpPWpGaD
Tacrolimus—Somnolence—Methotrexate—germ cell cancer	7.39e-05	0.00024	CcSEcCtD
Tacrolimus—ALB—Hemostasis—CD9—germ cell cancer	7.32e-05	0.0015	CbGpPWpGaD
Tacrolimus—Dyspepsia—Methotrexate—germ cell cancer	7.32e-05	0.000238	CcSEcCtD
Tacrolimus—MTOR—Immune System—PVRL2—germ cell cancer	7.32e-05	0.0015	CbGpPWpGaD
Tacrolimus—Decreased appetite—Methotrexate—germ cell cancer	7.23e-05	0.000235	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Methotrexate—germ cell cancer	7.18e-05	0.000233	CcSEcCtD
Tacrolimus—Fatigue—Methotrexate—germ cell cancer	7.17e-05	0.000233	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	7.16e-05	0.00146	CbGpPWpGaD
Tacrolimus—Pain—Methotrexate—germ cell cancer	7.11e-05	0.000231	CcSEcCtD
Tacrolimus—MTOR—Signaling by VEGF—HRAS—germ cell cancer	6.99e-05	0.00143	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—HRAS—germ cell cancer	6.94e-05	0.00142	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FGF4—germ cell cancer	6.86e-05	0.0014	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Methotrexate—germ cell cancer	6.85e-05	0.000223	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methotrexate—germ cell cancer	6.8e-05	0.000221	CcSEcCtD
Tacrolimus—FKBP1A—Disease—H2AFZ—germ cell cancer	6.78e-05	0.00138	CbGpPWpGaD
Tacrolimus—Urticaria—Methotrexate—germ cell cancer	6.61e-05	0.000215	CcSEcCtD
Tacrolimus—Abdominal pain—Methotrexate—germ cell cancer	6.58e-05	0.000213	CcSEcCtD
Tacrolimus—Body temperature increased—Methotrexate—germ cell cancer	6.58e-05	0.000213	CcSEcCtD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.53e-05	0.00133	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—KITLG—germ cell cancer	6.52e-05	0.00133	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—FGFR3—germ cell cancer	6.47e-05	0.00132	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.43e-05	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—KITLG—germ cell cancer	6.26e-05	0.00128	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—KITLG—germ cell cancer	6.24e-05	0.00127	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—OXT—germ cell cancer	6.23e-05	0.00127	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Methotrexate—germ cell cancer	6.13e-05	0.000199	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—H2AFZ—germ cell cancer	6.12e-05	0.00125	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—FGFR3—germ cell cancer	5.98e-05	0.00122	CbGpPWpGaD
Tacrolimus—Asthenia—Methotrexate—germ cell cancer	5.97e-05	0.000194	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—KIT—germ cell cancer	5.94e-05	0.00121	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—HRAS—germ cell cancer	5.94e-05	0.00121	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.93e-05	0.00121	CbGpPWpGaD
Tacrolimus—Pruritus—Methotrexate—germ cell cancer	5.88e-05	0.000191	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	5.88e-05	0.0012	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—HRAS—germ cell cancer	5.84e-05	0.00119	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.72e-05	0.00117	CbGpPWpGaD
Tacrolimus—Diarrhoea—Methotrexate—germ cell cancer	5.69e-05	0.000185	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—HRAS—germ cell cancer	5.68e-05	0.00116	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.64e-05	0.00115	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KITLG—germ cell cancer	5.63e-05	0.00115	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—germ cell cancer	5.6e-05	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—HRAS—germ cell cancer	5.59e-05	0.00114	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.51e-05	0.00113	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AVP—germ cell cancer	5.51e-05	0.00112	CbGpPWpGaD
Tacrolimus—Dizziness—Methotrexate—germ cell cancer	5.5e-05	0.000179	CcSEcCtD
Tacrolimus—PPP3CA—Disease—KIT—germ cell cancer	5.49e-05	0.00112	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—HRAS—germ cell cancer	5.37e-05	0.0011	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—HRAS—germ cell cancer	5.34e-05	0.00109	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FGF4—germ cell cancer	5.32e-05	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	5.31e-05	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—HRAS—germ cell cancer	5.31e-05	0.00109	CbGpPWpGaD
Tacrolimus—Vomiting—Methotrexate—germ cell cancer	5.29e-05	0.000172	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB2—HRAS—germ cell cancer	5.29e-05	0.00108	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—HRAS—germ cell cancer	5.26e-05	0.00107	CbGpPWpGaD
Tacrolimus—Rash—Methotrexate—germ cell cancer	5.24e-05	0.00017	CcSEcCtD
Tacrolimus—Dermatitis—Methotrexate—germ cell cancer	5.24e-05	0.00017	CcSEcCtD
Tacrolimus—Headache—Methotrexate—germ cell cancer	5.21e-05	0.000169	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	5.19e-05	0.00106	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	4.95e-05	0.00101	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—HRAS—germ cell cancer	4.95e-05	0.00101	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—HRAS—germ cell cancer	4.95e-05	0.00101	CbGpPWpGaD
Tacrolimus—Nausea—Methotrexate—germ cell cancer	4.94e-05	0.00016	CcSEcCtD
Tacrolimus—CYP3A7—Metabolism—SLC2A3—germ cell cancer	4.91e-05	0.001	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—HRAS—germ cell cancer	4.91e-05	0.001	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—HRAS—germ cell cancer	4.86e-05	0.000993	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—FGFR3—germ cell cancer	4.85e-05	0.00099	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—HRAS—germ cell cancer	4.84e-05	0.000989	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC22A3—germ cell cancer	4.84e-05	0.000989	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—H2AFZ—germ cell cancer	4.75e-05	0.00097	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—FGFR3—germ cell cancer	4.65e-05	0.000951	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—FGFR3—germ cell cancer	4.64e-05	0.000947	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FGF4—germ cell cancer	4.62e-05	0.000945	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—HRAS—germ cell cancer	4.58e-05	0.000936	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—KIT—germ cell cancer	4.45e-05	0.000909	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—HRAS—germ cell cancer	4.41e-05	0.000901	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	4.38e-05	0.000896	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KITLG—germ cell cancer	4.37e-05	0.000892	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—KIT—germ cell cancer	4.27e-05	0.000873	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FGF4—germ cell cancer	4.27e-05	0.000872	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AVP—germ cell cancer	4.27e-05	0.000872	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—KIT—germ cell cancer	4.26e-05	0.000869	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FGFR3—germ cell cancer	4.19e-05	0.000855	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CRABP1—germ cell cancer	3.95e-05	0.000806	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KIT—germ cell cancer	3.84e-05	0.000785	CbGpPWpGaD
Tacrolimus—MTOR—Disease—H2AFZ—germ cell cancer	3.81e-05	0.000779	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KITLG—germ cell cancer	3.8e-05	0.000776	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—germ cell cancer	3.76e-05	0.000768	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC2A3—germ cell cancer	3.55e-05	0.000726	CbGpPWpGaD
Tacrolimus—MTOR—Disease—KITLG—germ cell cancer	3.51e-05	0.000717	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—OXT—germ cell cancer	3.5e-05	0.000716	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC22A3—germ cell cancer	3.5e-05	0.000715	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—HRAS—germ cell cancer	3.37e-05	0.000689	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FGFR3—germ cell cancer	3.25e-05	0.000663	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC2A3—germ cell cancer	3.06e-05	0.000625	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MYC—germ cell cancer	3.02e-05	0.000617	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC22A3—germ cell cancer	3.01e-05	0.000616	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	3.01e-05	0.000615	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGF4—germ cell cancer	2.99e-05	0.000611	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KIT—germ cell cancer	2.98e-05	0.000609	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CRABP1—germ cell cancer	2.85e-05	0.000583	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FGFR3—germ cell cancer	2.82e-05	0.000577	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—HRAS—germ cell cancer	2.81e-05	0.000574	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.68e-05	0.000548	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—H2AFZ—germ cell cancer	2.67e-05	0.000545	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.64e-05	0.000539	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.64e-05	0.000539	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FGFR3—germ cell cancer	2.61e-05	0.000533	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KIT—germ cell cancer	2.59e-05	0.00053	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HRAS—germ cell cancer	2.57e-05	0.000525	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.55e-05	0.000522	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KITLG—germ cell cancer	2.46e-05	0.000502	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CRABP1—germ cell cancer	2.46e-05	0.000502	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AVP—germ cell cancer	2.4e-05	0.00049	CbGpPWpGaD
Tacrolimus—MTOR—Disease—KIT—germ cell cancer	2.39e-05	0.000489	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HRAS—germ cell cancer	2.37e-05	0.000485	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MYC—germ cell cancer	2.34e-05	0.000478	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CRABP1—germ cell cancer	2.15e-05	0.00044	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MYC—germ cell cancer	2.11e-05	0.000432	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.1e-05	0.000428	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—HRAS—germ cell cancer	1.92e-05	0.000393	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HRAS—germ cell cancer	1.85e-05	0.000377	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HRAS—germ cell cancer	1.84e-05	0.000376	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGFR3—germ cell cancer	1.83e-05	0.000373	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—germ cell cancer	1.74e-05	0.000355	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KIT—germ cell cancer	1.68e-05	0.000342	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HRAS—germ cell cancer	1.66e-05	0.000339	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.65e-05	0.000337	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MYC—germ cell cancer	1.64e-05	0.000335	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.63e-05	0.000332	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—germ cell cancer	1.35e-05	0.000275	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.33e-05	0.000271	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MYC—germ cell cancer	1.32e-05	0.000269	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HRAS—germ cell cancer	1.29e-05	0.000263	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HRAS—germ cell cancer	1.12e-05	0.000229	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—germ cell cancer	1.1e-05	0.000224	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HRAS—germ cell cancer	1.05e-05	0.000214	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HRAS—germ cell cancer	1.03e-05	0.000211	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MYC—germ cell cancer	9.22e-06	0.000188	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—germ cell cancer	7.57e-06	0.000155	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HRAS—germ cell cancer	7.24e-06	0.000148	CbGpPWpGaD
